| abstract |
It is intended to provide a preventive/remedy for diabetes characterized by comprising a combination of a renal sugar reabsorption inhibitor with a hypoglycemic agent. Use of the preventive/remedy makes it possible to correc t a high blood glucose levels after meal, between meals and in fasting. More specifically speaking, a therapeutic effect on diabetes which cannot be established by the existing hypoglycemic agents can be achieved thereby.</SD OAB> |